Avoid common mistakes on your manuscript.
Dear Reader,
Welcome to the final issue of Drugs in R&D for 2020.
This year has presented many challenges and I would like to take this opportunity to thank all who have contributed to ensuring the journal has thrived despite the extraordinary circumstances that the science community, and the world in general, has faced.
I would like to start by thanking the authors of the articles published in Drugs in R&D over the course of 2020. The enthusiasm of all authors for their chosen fields and their willingness to contribute content to the journal are crucial for its continued success.
The quality of published articles is also testament to the diligence of the peer reviewers, whose willingness to share their expertise ensures that the journal’s content is held to the highest standard. I would like to acknowledge the following individuals who acted as reviewers for Drugs in R&D in the last 12 months:
Gaetano Alfano, Italy
Luis Alou, Spain
Cristiano Amarelli, Italy
Bruno Annibale, Italy
Yoshimasa Aso, Japan
Teresa Bellón, Spain
Anthony Berdis, USA
Akshaya S. Bhagavathula, United Arab Emirates
Nick Bird, UK
Faith Cabbar, Turkey
Frédéric Carrière, Tunisia
Giannantonioi Cassisi, Italy
Chiranjib Chakraborty, India
Fei Wen Cheong, Malaysia
Kuo-Chen Chou, USA
Danny Cohn, the Netherlands
Jan de Jong, USA
Judith J. de Jong, The Netherlands
Luigi De Petris, Sweden
Mathias Due Buron, Denmark
Christine M. Durand, USA
Thomas R. Easterling, USA
Michael Fettiplace, USA
Daniel Fife, USA
Aron Fisher, USA
Bruno Frediani, Italy
William Freeman, USA
Francois Gaillard, France
Fernando Garcia-Souto, Spain
Valentina Garelli, Italy
Paul P.L. Giangrande, UK
Sebastiaan Goulooze, The Netherlands
Tingjie Guo, The Netherlands
Georg Hempel, Germany
Hans Hendriks, The Netherlands
Olaf Hoffmann, Germany
Jaroslav Hrenak, Slovakia
Richard Hughes, UK
Ken Ishii, Japan
Deepak Jakhar, India
Naoko Kanda, Japan
Vangelis Karalis, Greece
Merve Kasap, USA
Danielle Keulards, The Netherlands
Ganessan Kichenadasse, Australia
Stephan Kraehenbuehl, Switzerland
Gregory Krauss, USA
Jerrold H. Levy, USA
Hanbin Li, USA
Matthias Löhr, Sweden
Osama Loubani, Canada
Johnny N. Mahlangu, South Africa
Edoardo Marrani, Italy
Franz H. Messerli, Switzerland
Theresia Metoh, Cameroon
Pavel Mozgunov, UK
Francisco Navarro-Triviño, Spain
David D.P. Nicolau, USA
Ross Norris, Australia
Roisin E. O'Cearbhaill, USA
Anna Ockerman, Belgium
Win Min Oo, Australia
Manjunath P. Pai, USA
Antoine Petitcollin, France
Sara-Joan Pinto-Sietsma, The Netherlands
Akshanth R. Polepally, USA
Rosa L. Potenza, Italy
Motiur Rahman, USA
Robert Rubin, USA
Jesus Ruiz Ruiz Ramos, Spain
Izabela Rusiecka, Poland
Eleftherios P. Samartzis, Switzerland
Cheryl Sargel, USA
Andrea Savarino, Italy
Gianantonio Saviola, Italy
Jean-Michel Scherrmann, France
Edward Schmidt, USA
Arun Singh, USA
Romain Siriez, Belgium
Hemant K. Srivastava, India
Norbert Stefan, Germany
Raman Sureshkumar, India
Navin Suthahar, The Netherlands
Derek Taylor, USA
Hiroki Teragawa, Japan
Alison H. Thomson, UK
Dick Tibboel, The Netherlands
Andreas Tiede, Germany
Laszlo Tothfalusi, Hungary
Timir Tripathi, India
Georgios Tsivgoulis, Greece
Geoffrey T. Tucker, UK
Susanne Urach, Austria
Edward T. Van Matre, USA
Maurice van Steensel, The Netherlands
Marcel Van't Veer, the Netherlands
Francisco Vílchez-Oya, Spain
Thomas Weiser, Germany
Kyle J. Wilby, New Zealand
Uwe Wollina, Germany
Hongmei Xu, USA
Satoshi Yamaguchi, Japan
Victoria C. Ziesenitz, Germany
I am also very grateful to the members of the journal’s Honorary Editorial Board, who have acted as peer reviewers and authors, and have provided guidance on journal content, policy and processes:
G. An, University of Iowa, Iowa, IA, USA
D. Cattaneo, Luigi Sacco University Hospital, Milan, Italy
G. Cherala, Eastern Virginia Medical School, Norfolk, VA, USA
P.G. Cojutti, University of Udine, Udine, Italy
R.P. Dash, Johns Hopkins School of Medicine, Baltimore, MD, USA
R. Giusti, Sant'Andrea Hospital of Rome, Rome, Italy
C. Guillén-Ponce, Hospital Universitario Ramón y Cajal, Madrid, Spain
Y. K. Gupta, All India Institute of Medical Sciences, New Delhi, India
H. P. Hartung, Heinrich-Heine University, Dusseldorf, Germany
C. Höcht, University of Buenos Aires, Buenos Aires, Argentina
F. Jamali, University of Alberta, Edmonton, AB, Canada
T.K.L. Kiang, The University of British Columbia, Vancouver, BC, Canada
M.J. McKeage, University of Auckland, Auckland, New Zealand
S. Mercadante, La Maddalena Cancer Center, Palermo, Italy
S. Misaka, Fukushima Medical University, Fukushima, Japan
P. J. Nathan, Monash University, Melbourne, VIC, Australia
J. Niu, FDA*, Silver Spring, MD, USA
B.M. Patel, Nirma University, Ahmedabad, India
S. Perez-Lloret, Institute for Cardiology Research, National Research Council (ININCA-UBA-CONICET), Buenos Aires, Argentina
M. Pfister, University of Basel, Basel, Switzerland
G. Remington, University of Toronto, Toronto, ON, Canada
H. Schütz, BEBAC Consulting, Vienna, Austria
Y. Saisho, Keio University School of Medicine, Tokyo, Japan
M. H. Shishehbor, Cleveland Clinic Cardiovascular Disease, Cleveland, OH, USA
L.P. Shulman, Feinberg School of Medicine of Northwestern University, Chicago, IL, USA
G. Singhania, CHI St. Vincent Infirmary, Little Rock, AK, USA
L. Tóthfalusi, Semmelweis University, Budapest, Hungary
J. Weiss, University of Heidelberg, Heidelberg, Germany
S. Yamada, Diabetes Center, Kitasato Institute Hospital, Tokyo, Japan
*Dr Niu is serving in her personal capacity
The COVID-19 pandemic has reinforced the importance of rapid and wide dissemination of high-quality information. Springer Nature is supporting the global response to COVID-19 by making all relevant content immediately and freely available.
The high quality of the content published in Drugs in R&D has been reflected in the most recent impact factor of 2.277. This places the journal in the second quartile of the pharmacology and pharmacy category. The journal also achieved a Citescore of 4.2, placing it at position 124/301 in the pharmacology category.
In 2021, Drugs in R&D will continue to provide you with high interest, clinically relevant content in the field of pharmacology. I thank you for your continued support.
With best wishes,
Anton van Rensburg
Editor-in-Chief
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
About this article
Cite this article
Acknowledgement to Referees. Drugs R D 20, 291–293 (2020). https://doi.org/10.1007/s40268-020-00328-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40268-020-00328-x